Your browser doesn't support javascript.
loading
Chronic graft-versus-host disease and inhibition of interleukin-17: proof of concept in humans.
Debureaux, P-E; de Masson, A; Battistella, M; Sicre de Fontbrune, F; Socié, G; Bouaziz, J D; Michonneau, D.
Affiliation
  • Debureaux PE; Hematology and Transplantation Unit, Saint Louis Hospital, APHP, Paris, France.
  • de Masson A; Dermatology Unit, Saint Louis Hospital, APHP, Paris, France.
  • Battistella M; Université de Paris, INSERM U976, Paris, France.
  • Sicre de Fontbrune F; Pathology Department, Saint Louis Hospital, APHP, Paris, France.
  • Socié G; Hematology and Transplantation Unit, Saint Louis Hospital, APHP, Paris, France.
  • Bouaziz JD; Hematology and Transplantation Unit, Saint Louis Hospital, APHP, Paris, France.
  • Michonneau D; Université de Paris, INSERM U976, Paris, France.
Br J Dermatol ; 182(4): 1038-1041, 2020 04.
Article in En | MEDLINE | ID: mdl-31175666
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2020 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2020 Type: Article Affiliation country: France